drugset / Trial / NCT00996307

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

NCT00996307 ↗

Phase 2/3 Completed 654 enrolled Novartis Vaccines Novartis · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 2009 (swine flu) vaccine in healthy young children

Timeline

Start
2009-10
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MF59-eH1N1_f Vaccine 3.75 ug —
Subject MF59-eH1N1_f Vaccine 7.5 ug —
Subject MF59-eH1N1_f Vaccine 15 ug —

Indications